{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:43:29Z","timestamp":1791895409122,"version":"4.3.4"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec id=\"ab-soi230042-4\"><jats:title>Importance<\/jats:title><jats:p>The treatment for extraperitoneal locally advanced rectal cancer (LARC) is neoadjuvant therapy (NAT) followed by total mesorectal excision (TME). Robust evidence on the optimal time interval between NAT completion and surgery is lacking.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-5\"><jats:title>Objective<\/jats:title><jats:p>To assess the association of time interval between NAT completion and TME with short- and long-term outcomes. It was hypothesized that longer intervals increase the pathologic complete response (pCR) rate without increasing perioperative morbidity.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study included patients with LARC from 6 referral centers who completed NAT and underwent TME between January 2005 and December 2020. The cohort was divided into 3 groups depending on the time interval between NAT completion and surgery: short (\u22648 weeks), intermediate (&amp;amp;gt;8 and \u226412 weeks), and long (&amp;amp;gt;12 weeks). The median follow-up duration was 33 months. Data analyses were conducted from May 1, 2021, to May 31, 2022. The inverse probability of treatment weighting method was used to homogenize the analysis groups.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-7\"><jats:title>Exposure<\/jats:title><jats:p>Long-course chemoradiotherapy or short-course radiotherapy with delayed surgery.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-8\"><jats:title>Main outcome and Measures<\/jats:title><jats:p>The primary outcome was pCR. Other histopathologic results, perioperative events, and survival outcomes constituted the secondary outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-9\"><jats:title>Results<\/jats:title><jats:p>Among the 1506 patients, 908 were male (60.3%), and the median (IQR) age was 68.8 (59.4-76.5) years. The short-, intermediate-, and long-interval groups included 511 patients (33.9%), 797 patients (52.9%), and 198 patients (13.1%), respectively. The overall pCR was 17.2% (259 of 1506 patients; 95% CI, 15.4%-19.2%). When compared with the intermediate-interval group, no association was observed between time intervals and pCR in short-interval (odds ratio [OR], 0.74; 95% CI, 0.55-1.01) and long-interval (OR, 1.07; 95% CI, 0.73-1.61) groups. The long-interval group was significantly associated with lower risk of bad response (tumor regression grade [TRG] 2-3; OR, 0.47; 95% CI, 0.24-0.91), systemic recurrence (hazard ratio, 0.59; 95% CI, 0.36-0.96), higher conversion risk (OR, 3.14; 95% CI, 1.62-6.07), minor postoperative complications (OR, 1.43; 95% CI, 1.04-1.97), and incomplete mesorectum (OR, 1.89; 95% CI, 1.02-3.50) when compared with the intermediate-interval group.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230042-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Time intervals longer than 12 weeks were associated with improved TRG and systemic recurrence but may increase surgical complexity and minor morbidity.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2023.2521","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T15:03:22Z","timestamp":1689174202000},"page":"910","source":"Crossref","is-referenced-by-count":32,"title":["Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS Study"],"prefix":"10.1001","volume":"158","author":[{"given":"Yoelimar","family":"Guzm\u00e1n","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"R\u00edos","sequence":"additional","affiliation":[{"name":"Department of Clinical Farmacology, Hospital Clinic and Medical Statistics Core Facility, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Biostatistics Unit, Faculty of Medicine, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Paredes","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Hospital Cl\u00ednico Universitario de Santiago, Santiago de Compostela, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Maurel","sequence":"additional","affiliation":[{"name":"Medical Oncology Departments, Hospital Cl\u00ednic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gonz\u00e1lez-Ab\u00f3s","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Otero-Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Almenara","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ladra","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Hospital Cl\u00ednico Universitario de Santiago, Santiago de Compostela, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Prada","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Hospital Cl\u00ednico Universitario de Santiago, Santiago de Compostela, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pascual","sequence":"additional","affiliation":[{"name":"General Surgery Department, Section of Colon and Rectal Surgery Unit, Hospital del Mar, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Guerrero","sequence":"additional","affiliation":[{"name":"General Surgery Department, Section of Colon and Rectal Surgery Unit, Hospital del Mar, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Garc\u00eda-Granero","sequence":"additional","affiliation":[{"name":"Coloproctology Unit, Health Research Institute of the Balearic Islands, 3D-Reconstruction Unit and Simulation Center, Hospital Universitario Son Espases, Professor of Human Embriology and Anatomy Department, University of Islas Baleares, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Coloproctology Unit, Hospital Universitario Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Ochogavia-Segu\u00ed","sequence":"additional","affiliation":[{"name":"Coloproctology Unit, Hospital Universitario Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Gamundi-Cuesta","sequence":"additional","affiliation":[{"name":"Coloproctology Unit, Hospital Universitario Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc Xavier","family":"Gonz\u00e1lez-Argente","sequence":"additional","affiliation":[{"name":"Coloproctology Unit, Hospital Universitario Son Espases, Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Viso","family":"Pons","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Consorci Sanitari Integral - Hospital General de l\u2019Hospitalet, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Centeno","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Consorci Sanitari Integral - Hospital General de l\u2019Hospitalet, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Array\u00e1s","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Consorci Sanitari Integral - Hospital General de l\u2019Hospitalet, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Miguel","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Colorectal Surgery Unit, Consorci Sanitari Integral - Hospital General de l\u2019Hospitalet, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gil-G\u00f3mez","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Gil","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"General and Digestive Surgery Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Lacy","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"},{"name":"Chief of Instituto Quir\u00fargico Lacy, Barcelona, Catalonia, Spain"},{"name":"Clinica Rotger, Palma de Mallorca, Spain"},{"name":"Hospital Ruber Internacional, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Borja","family":"de Lacy","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Institute of Digestive and Metabolic Diseases, Hospital Clinic of Barcelona, University of Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8843","key":"soi230042r1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","article-title":"Mesorectal excision for rectal cancer.","volume":"341","author":"MacFarlane","year":"1993","journal-title":"Lancet"},{"issue":"11","key":"soi230042r2","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1245\/s10434-016-5294-0","article-title":"Treatment interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients: a population-based study.","volume":"23","author":"Rombouts","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"soi230042r3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/SLA.0000000000000368","article-title":"Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies.","volume":"263","author":"Petrelli","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"soi230042r4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/01.sla.0000161980.46459.96","article-title":"Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.","volume":"241","author":"Guillem","year":"2005","journal-title":"Ann Surg"},{"issue":"34","key":"soi230042r5","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.","volume":"23","author":"R\u00f6del","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"soi230042r6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"issue":"1","key":"soi230042r7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1245\/s10434-017-6213-8","article-title":"Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near-complete response?","volume":"25","author":"Hupkens","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"soi230042r8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1245\/s10434-018-07097-7","article-title":"Cross-sectional study on MRI restaging after chemoradiotherapy and interval to surgery in rectal cancer: influence on short- and long-term outcomes.","volume":"26","author":"Detering","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"soi230042r9","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","article-title":"Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial.","volume":"32","author":"Fokas","year":"2014","journal-title":"J Clin Oncol"},{"issue":"9","key":"soi230042r10","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","article-title":"Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis.","volume":"19","author":"Zorcolo","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"soi230042r11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4174\/jkss.2013.84.6.338","article-title":"Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.","volume":"84","author":"Jeong","year":"2013","journal-title":"J Korean Surg Soc"},{"issue":"4","key":"soi230042r12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/SLA.0b013e3181b91e63","article-title":"Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.","volume":"250","author":"Kalady","year":"2009","journal-title":"Ann Surg"},{"issue":"31","key":"soi230042r13","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6).","volume":"34","author":"Lefevre","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"soi230042r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy.","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10139","key":"soi230042r15","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"issue":"9596","key":"soi230042r16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"soi230042r17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/codi.v22.3","article-title":"Randomized controlled trial of 8 weeks\u2019 vs 12 weeks\u2019 interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer.","volume":"22","author":"Terzi","year":"2020","journal-title":"Colorectal Dis"},{"issue":"2","key":"soi230042r18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging.","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"soi230042r19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"25","key":"soi230042r20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"8","key":"soi230042r21","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"issue":"10","key":"soi230042r22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.clon.2013.06.007","article-title":"Biological consequences of radiation-induced DNA damage: relevance to radiotherapy.","volume":"25","author":"Lomax","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"soi230042r23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clon.2008.10.011","article-title":"Regression of rectal cancer with radiotherapy with or without concurrent capecitabine\u2013optimising the timing of surgical resection.","volume":"21","author":"Dhadda","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"soi230042r24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/bjs.11220","article-title":"Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.","volume":"106","author":"Ryan","year":"2019","journal-title":"Br J Surg"},{"issue":"9","key":"soi230042r25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4251\/wjgo.v8.i9.695","article-title":"Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer.","volume":"8","author":"Mihmanli","year":"2016","journal-title":"World J Gastrointest Oncol"},{"issue":"9","key":"soi230042r26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"soi230042r27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/DCR.0b013e31828aedcb","article-title":"Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.","volume":"56","author":"Foster","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"soi230042r28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ijrobp.2015.10.061","article-title":"Pathologic response, when increased by longer interval, is a marker but not the cause of good prognosis in rectal cancer: 17-year Follow-up of the Lyon R90-01 randomized trial.","volume":"94","author":"Cotte","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"soi230042r29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/SLA.0000000000003530","article-title":"Does a longer waiting period after neoadjuvant radiochemotherapy improve the oncological prognosis of rectal cancer\u20143 years\u2019 follow-up results of the GRECCAR-6 randomized multicenter trial.","volume":"270","author":"Lef\u00e8vre","year":"2019","journal-title":"Ann Surg"},{"key":"soi230042r30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.radonc.2020.09.026","article-title":"Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials.","volume":"154","author":"Gambacorta","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"soi230042r31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/jgo","article-title":"Pathologic complete response and disease-free survival are not surrogate end points for 5-year survival in rectal cancer: an analysis of 22 randomized trials.","volume":"8","author":"Petrelli","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"soi230042r32","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses.","volume":"175","author":"Prasad","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8514","key":"soi230042r33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","article-title":"Local recurrence of rectal adenocarcinoma due to inadequate surgical resection\u2014histopathological study of lateral tumour spread and surgical excision.","volume":"2","author":"Quirke","year":"1986","journal-title":"Lancet"},{"issue":"7","key":"soi230042r34","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.2002.07.010","article-title":"Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.","volume":"20","author":"Nagtegaal","year":"2002","journal-title":"J Clin Oncol"},{"issue":"11","key":"soi230042r35","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1007\/s00261-019-02012-4","article-title":"Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemoradiotherapy.","volume":"44","author":"Napoletano","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"soi230042r36","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment.","volume":"22","author":"Maas","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"soi230042r37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1055\/s-0037-1606213","article-title":"Is propensity score analysis a valid surrogate of randomization for the avoidance of allocation bias?","volume":"37","author":"Torres","year":"2017","journal-title":"Semin Liver Dis"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2806989\/jamasurgery_guzmn_2023_oi_230042_1694030420.44331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:08:49Z","timestamp":1694617729000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2806989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.2521","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}